[Schizophrenia: receptors and clinical aspects].
Growing knowledge in receptors and clinical aspects of schizophrenia has led to new models of understanding. These models emphasize the role of anxious and depressive dimensions in the constitution of clinical symptomatology. A more precise evaluation of these dimensions seems necessary to try to discover more specific drugs.
Azorin
J M
JM
CHU Sainte-Marguerite, Marseille.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000503:physiopathology; D006801:Humans; D011569:Psychiatric Status Rating Scales; D017981:Receptors, Neurotransmitter / Q000187:drug effects / Q000502:physiology*; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D017981:Receptors, Neurotransmitter